CRI 📈 Carter’s - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1462291097
CRI: Children's Clothing, Accessories, Toys, Furniture, Bedding, Home Decor
Carter's, Inc., together with its subsidiaries, designs, sources, and markets branded childrenswear under the Carter's, OshKosh, Skip Hop, Child of Mine, Just One You, Simple Joys, Little Planet, and other brands in the United States and internationally. It operates through three segments: U.S. Retail, U.S. Wholesale, and International. The company's Carter's products include babies and young children products, such as bodysuits, layette essentials, sleep and play, pants, tops and t-shirts, multipiece sets, dresses, and sleepwear; and OshKosh brand products comprise playclothes, such as denim jeans, overalls, core bottoms, knit tops, t-shirts, and layering pieces. It provides products for playtime, travel, mealtime, bath time, and home gear, as well as kid's bags under the Skip Hop brand. In addition, the company offers bedding, home décor, cribs and baby furniture, diaper bags, footwear, gift sets, hair accessories, jewelry, outerwear, paper goods, socks, shoes, swimwear, and toys. The company operates through wholesale locations, including department stores, national chain stores, and specialty stores, as well as retail stores. It sells its products through its eCommerce websites, such as carters.com, oshkosh.com, skiphop.com, and mobile application, as well as other international wholesale accounts and licensees. Carter's, Inc. was founded in 1865 and is headquartered in Atlanta, Georgia. Web URL: https://www.carters.com
Additional Sources for CRI Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CRI Stock Overview
Market Cap in USD | 1,976m |
Sector | Consumer Cyclical |
Industry | Apparel Retail |
GiC Sub-Industry | Apparel, Accessories & Luxury Goods |
IPO / Inception | 2003-10-24 |
CRI Stock Ratings
Growth 5y | -66.0% |
Fundamental | 42.6% |
Dividend | 73.7% |
Rel. Strength Industry | -176 |
Analysts | 2.8/5 |
Fair Price Momentum | 49.53 USD |
Fair Price DCF | 199.31 USD |
CRI Dividends
Dividend Yield 12m | 5.75% |
Yield on Cost 5y | 3.36% |
Annual Growth 5y | 8.45% |
Payout Consistency | 93.8% |
CRI Growth Ratios
Growth Correlation 3m | -57.8% |
Growth Correlation 12m | -82.1% |
Growth Correlation 5y | -57.5% |
CAGR 5y | -10.20% |
CAGR/Mean DD 5y | -0.42 |
Sharpe Ratio 12m | -0.78 |
Alpha | -46.75 |
Beta | 0.97 |
Volatility | 35.63% |
Current Volume | 9526.9k |
Average Volume 20d | 1462.7k |
What is the price of CRI stocks?
As of December 22, 2024, the stock is trading at USD 55.64 with a total of 9,526,946 shares traded.
Over the past week, the price has changed by -0.09%, over one month by +10.80%, over three months by -15.79% and over the past year by -22.33%.
As of December 22, 2024, the stock is trading at USD 55.64 with a total of 9,526,946 shares traded.
Over the past week, the price has changed by -0.09%, over one month by +10.80%, over three months by -15.79% and over the past year by -22.33%.
Is Carter’s a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Carter’s (NYSE:CRI) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 42.58 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CRI as of December 2024 is 49.53. This means that CRI is currently overvalued and has a potential downside of -10.98%.
Partly, yes. Based on ValueRay Fundamental Analyses, Carter’s (NYSE:CRI) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 42.58 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CRI as of December 2024 is 49.53. This means that CRI is currently overvalued and has a potential downside of -10.98%.
Is CRI a buy, sell or hold?
Carter’s has received a consensus analysts rating of 2.80. Therefor, it is recommend to hold CRI.
Carter’s has received a consensus analysts rating of 2.80. Therefor, it is recommend to hold CRI.
- Strong Buy: 0
- Buy: 0
- Hold: 4
- Sell: 1
- Strong Sell: 0
What are the forecast for CRI stock price target?
According to ValueRays Forecast Model, CRI Carter’s will be worth about 54.2 in December 2025. The stock is currently trading at 55.64. This means that the stock has a potential downside of -2.61%.
According to ValueRays Forecast Model, CRI Carter’s will be worth about 54.2 in December 2025. The stock is currently trading at 55.64. This means that the stock has a potential downside of -2.61%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 56.3 | 1.1% |
Analysts Target Price | 70.1 | 26.1% |
ValueRay Target Price | 54.2 | -2.6% |